A tighter archive for life-science signals.
Search once, then narrow by source or topic.
10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus
10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus
10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus
10x Genomics (TXG) Maintains Buy Rating, Price Target Raised to $20 | TXG Stock News - GuruFocus
10x Genomics (NASDAQ:TXG) Given New $20.00 Price Target at Canaccord Genuity Group - MarketBeat
10x Genomics (NASDAQ:TXG) Given New $20.00 Price Target at Canaccord Genuity Group - MarketBeat
Lancaster Investment Management Purchases Shares of 621,779 10x Genomics $TXG - MarketBeat
Lancaster Investment Management Purchases Shares of 621,779 10x Genomics $TXG - MarketBeat
Is 10x Genomics Inc. stock a safe haven asset - Quarterly Performance Summary & Technical Confirmation Alerts - DonanımHaber
Is 10x Genomics Inc. stock a safe haven asset - Quarterly Performance Summary & Technical Confirmation Alerts - DonanımHaber
Executive Q&A Video: SPT Labtech and 10x Genomics on Automating Single-Cell Workflows - GenomeWeb
Executive Q&A Video: SPT Labtech and 10x Genomics on Automating Single-Cell Workflows - GenomeWeb
BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Announces Target Price $18 - 富途牛牛
BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Announces Target Price $18 - 富途牛牛
10x Genomics price target raised to $22 from $17 at Barclays - TipRanks
10x Genomics price target raised to $22 from $17 at Barclays - TipRanks
Spatial Transcriptomics Market Is Going to Boom |• 10X Genomics • Illumina - openPR.com
Spatial Transcriptomics Market Is Going to Boom |• 10X Genomics • Illumina - openPR.com
10x Genomics $TXG Position Increased by Nikko Asset Management Americas Inc. - MarketBeat
10x Genomics $TXG Position Increased by Nikko Asset Management Americas Inc. - MarketBeat
Why The Narrative Around 10x Genomics Is Shifting After New Institutional Buying And Product Updates - Yahoo Finance
Why The Narrative Around 10x Genomics Is Shifting After New Institutional Buying And Product Updates - Yahoo Finance
Bellevue Group AG Buys 95,754 Shares of 10x Genomics $TXG - MarketBeat
Bellevue Group AG Buys 95,754 Shares of 10x Genomics $TXG - MarketBeat
Citi downgrades 10x Genomics (TXG) to a Hold - The Globe and Mail
Citi downgrades 10x Genomics (TXG) to a Hold - The Globe and Mail
10x Genomics (TXG) Q4 2024 Earnings Transcript - AOL.com
10x Genomics (TXG) Q4 2024 Earnings Transcript - AOL.com
10x Genomics (TXG) Q2 2025 Earnings Transcript - AOL.com
10x Genomics (TXG) Q2 2025 Earnings Transcript - AOL.com
TXG: Citigroup Downgrades 10x Genomics to Neutral with $18 Price Target | TXG Stock News - GuruFocus
TXG: Citigroup Downgrades 10x Genomics to Neutral with $18 Price Target | TXG Stock News - GuruFocus
10x Genomics (TXG) Q2 2025 Earnings Transcript - The Motley Fool
10x Genomics (TXG) Q2 2025 Earnings Transcript - The Motley Fool
Citi Downgrades 10x Genomics(TXG.US) to Hold Rating, Raises Target Price to $18 - 富途牛牛
Citi Downgrades 10x Genomics(TXG.US) to Hold Rating, Raises Target Price to $18 - 富途牛牛
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page